RECORDATI
🇮🇹Italy
- Country
- 🇮🇹Italy
- Ownership
- Private
- Established
- 1926-01-01
- Employees
- 501
- Market Cap
- $12B
- Website
- https://www.recordati.com.tr
Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential Hypertension
Phase 2
Completed
- Conditions
- Essential Hypertension
- Interventions
- First Posted Date
- 2010-03-26
- Last Posted Date
- 2011-04-29
- Lead Sponsor
- RECORDATI GROUP
- Target Recruit Count
- 1039
- Registration Number
- NCT01093807
- Locations
- 🇫🇷
Hôpital de la Pitié-Salpétrière, Paris, France
Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH
Phase 3
Completed
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- First Posted Date
- 2006-08-03
- Last Posted Date
- 2009-02-19
- Lead Sponsor
- RECORDATI GROUP
- Target Recruit Count
- 1228
- Registration Number
- NCT00359905
- Locations
- 🇬🇧
Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath